ORG Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$342K Buy
3,560
+1,308
+58% +$127K 0.06% 253
2025
Q3
$214K Buy
2,252
+240
+12% +$22.1K 0.04% 334
2025
Q2
$179K Buy
2,012
+183
+10% +$15.5K 0.04% 340
2025
Q1
$162K Sell
1,829
-302
-14% -$27K 0.04% 307
2024
Q4
$170K Sell
2,131
-66
-3% -$5.71K 0.02% 348
2024
Q3
$198K Sell
2,197
-1,806
-45% -$152K 0.03% 284
2024
Q2
$309K Buy
+4,003
New +$328K 0.04% 325
2024
Q1
Sell
-59
Closed -$4.86K 864
2023
Q4
$4.86K Sell
59
-2,167
-97% -$165K ﹤0.01% 854
2023
Q3
$174K Sell
2,226
-5,540
-71% -$464K 0.05% 306
2023
Q2
$681K Buy
+7,766
New +$669K 0.11% 169

Other funds holding MDT

ORG Partners's MDT Position: Q4 2025 in Review

ORG Partners increased its Medtronic (MDT) stake by 58% in Q4 2025, buying an estimated $127K and bringing the position to 3,560 shares worth $342K. The position accounts for 0.06% of the portfolio, ranked #253.

ORG Partners first reported a position in MDT in Q2 2023 and has held it in 10 quarters since. The position peaked at $681K in Q2 2023. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • ORG Partners held 3,560 shares of Medtronic worth $342K as of Q4 2025.
  • ORG Partners bought 1,308 Medtronic shares in Q4 2025, an estimated $127K.
  • Medtronic made up 0.06% of ORG Partners's portfolio in Q4 2025, its #253 holding.
  • ORG Partners first reported a position in Medtronic in Q2 2023 and has held it in 10 quarters since.
  • ORG Partners's Medtronic position peaked at $681K in Q2 2023.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.